Concord Medical Services Holdings vs Newgenivf Group
Concord Medical Services Holdings is the larger business, with $64.1m of revenue in fiscal 2025 against $23.7m for Newgenivf Group (2.7 times as much). Newgenivf Group grew faster (336.3% against 20.1%). Newgenivf Group kept more of each dollar of sales as profit: a net margin of 41.7% against -20.2%.
| Latest fiscal year | Concord Medical Services HoldingsCCM, 2025 | Newgenivf GroupNIVF, 2025 |
|---|---|---|
| Revenue | $64.1m | $23.7m |
| Revenue growth | 20.1% | 336.3% |
| Net income | −$12.9m | $9.9m |
| Operating margin | -56.8% | -45.2% |
| Net margin | -20.2% | 41.7% |
| Return on equity | — | 77.2% |
| Free cash flow | −$35.9m | −$11.1m |
| Cash | $42.6m | $758,621 |
| Total debt | $493m | $4.4m |
| Debt to equity | — | 16.4% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | — |
| Market value | $16.1m | $202,122 |
| Price vs our value range | — | — |
| Moat score | 28 (Weak) | — |
| Insider trades, 12 months | 0 buys, 0 sales | 8 buys, 2 sales |